Canadian Medical Association Journal
August 20, 2015
Carolyn Brown, Ottawa, ON
The first vaccine against malaria — and the first against any parasitical disease in humans — has limited efficacy in children of 27% to 39%, but it's still a useful tool in combatting a long-standing and dire disease, say experts.
"The pattern of disease arising from malaria is still very high" despite measures such as insecticidal bed nets and clearing brush, which is why a vaccine is welcome, explains Dr. Githinji Gitahi, chief executive officer of Amref Health Africa, a humanitarian organization providing training and health services in more than 30 countries, including those most affected by malaria.